Stocktoria
Tarsus Pharmaceuticals, Inc. TARS
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-10-16
Tarsus Pharmaceuticals, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 3,266,714 | $88.8M | 7.68% |
| D. E. Shaw & Co., Inc. | 791,146 | $55.5M | 1.86% |
| MILLENNIUM MANAGEMENT LLC | 594,579 | $41.7M | 1.4% |
| Point72 Asset Management, L.P. | 226,251 | $15.9M | 0.53% |
| CITADEL ADVISORS LLC | 183,097 | $12.8M | 0.43% |
| RENAISSANCE TECHNOLOGIES LLC | 73,400 | $5.1M | 0.17% |
| AQR CAPITAL MANAGEMENT LLC | 30,453 | $2.1M | 0.07% |
| TWO SIGMA INVESTMENTS, LP | 19,078 | $1.3M | 0.04% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.